DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Avoiding Risk With Nonadherent Patients

by Ann McNary, JD Ms. McNary is Senior Risk Manager, Professional Risk Management Services, Arlington, Virginia. Innov Clin Neurosci. 2015;12(3–4):37–40.

A message from the chair, ISCTM Scientific Publications

Dear Colleagues: Twice a year, the International Society for CNS Clinical Trials and Methodology (ISCTM) brings together academic researchers, policy makers, and industry and government representatives to focus on promoting

Translational and Early Phase Strategies for Treatment Development: Report of ISCTM Autumn 2013 Symposium

by Jared W. Young, PhD; William Z. Potter, MD, PhD; Steve Riley, PharmD, PhD; Geert J. Groeneveld, MD, PhD; Bruce J. Kinon, MD; Mike F. Egan, MD; and Douglas E.